Results 91 to 100 of about 15,047 (197)

Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials

Comprehensive Psychiatry, 2019
Background: The effects of the combination therapy of varenicline and bupropion in smoking cessation are still controversial. Methods: Databases including PubMed, EMBASE, Cochrane Library and Web of Science were scanned without time and language ...
Zhaoshuang Zhong, Shijie Zhao, Yan Zhao, Shuyue Xia   +3 more
doaj   +1 more source

Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism [PDF]

, 2016
Background This study examined whether varenicline (VAR), or naltrexone (NTX), alone or in combination, reduces alcohol drinking in alcohol-preferring (P) rats with a genetic predisposition toward high voluntary alcohol intake.
Dilley, Julian E., Filosa, Nick, Fischer, Stephen M., Froehlich, Janice C., Nicholson, Emily, Rademacher, Logan, Smith, Teal   +6 more
core   +4 more sources

Smoking Cessation Agents and Suicide [PDF]

, 2009
The risk is uncertain, so patients should make an informed ...
Lavigne, Jill E
core   +2 more sources

Efficacy of Varenicline in Smoking Cessation—A Systematic Review and Meta-analysis

Journal of Indian Academy of Oral Medicine and Radiology
Background: Tobacco use is a leading cause of morbidity and mortality. Smoking cessation significantly reduces related health risks. Varenicline, a partial nicotine receptor agonist, may aid cessation by reducing cigarette consumption and dependence ...
Reethu Ravichandiran, Venkatesh Jayaraman, Ramasamy Sarvathikari, Ramya Kalyanasundaram, Vijayalakshmi Lakshmanan, Sakthivel Sambasivam   +5 more
doaj   +1 more source

Real world evaluation of three models of NHS smoking cessation service in England [PDF]

, 2012
Background NHS Stop Smoking Services provide various options for support and counselling. Most services have evolved to suit local needs without any retrospective evaluation of their efficiency.
Tony Mardle, Shirley Merrett, Jane Wright, Fran Percival, Ian Lockhart   +4 more
core   +2 more sources

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. [PDF]

, 2012
n/
DE MICHELE, GIUSEPPE, FILLA, ALESSANDRO, SACCA', FRANCESCO   +2 more
core   +1 more source

Helping Smokers Quit: State Cessation Coverage [PDF]

, 2008
Analyzes state health insurance coverage for treatments to quit smoking and how coverage through state Medicaid, state employee health plans, private insurance, and "quitlines" saves states healthcare costs.

core  

Vareniclina en el tratamiento del tabaquismo: efi cacia y seguridad en población general, psiquiátrica y drogodependiente [PDF]

, 2013
Desde el año 2006 la vareniclina se está utilizando como tratamiento de primera elección para dejar de fumar. La mayoría de estudios publicados sobre efi cacia y seguridad de este producto se han hecho sobre muestras de fumadores sanos.
Ballbè Gibernau, Montse, Carcolé Batet, Blanca, Mondon Vehils, Silvia, Nieva Rifá, Gemma, Pinet Ogué, Mª Cristina, Roig Cutillas, Pilar, Serrano Jordán, Jaume   +6 more
core  

Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan.

PLoS ONE, 2016
Background and objectiveRelative effectiveness of smoking cessation medications-varenicline, bupropion and nicotine replacement therapy (NRT)-remains unclear among smokers in real-world settings.
Po-Yin Chang, Po-Ching Lo, Hui-Chin Chang, Kuang-Chieh Hsueh, Yi-Wen Tsai   +4 more
doaj   +1 more source

Varenicline [PDF]

Reactions Weekly, 2020
openaire   +2 more sources